Home
About
Overview
Sharing Data
ORCID
Help
History (19)
Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX.
Comparison of Intracerebral Hemorrhage Volume Calculation Methods and Their Impact on Scoring Tools.
Advantages and Limitations of Wearable Activity Trackers: Considerations for Patients and Clinicians.
Lack of anti-tumor activity with the ?-catenin expression inhibitor EZN-3892 in the C57BL/6J Min/+ model of intestinal carcinogenesis.
Re: Comparison of risk adjustment methodologies in surgical quality improvement.
See All 19 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Re: Comparison of risk adjustment methodologies in surgical quality improvement.
Meurer S, Keroack M, Sabel A. Re: Comparison of risk adjustment methodologies in surgical quality improvement. Surgery. 2009 Jul; 146(1):128.
View in:
PubMed
subject areas
Academic Medical Centers
Databases as Topic
General Surgery
Humans
Ohio
Quality Assurance, Health Care
Risk Adjustment
authors with profiles
Mark A Keroack MD, MPH